程蔚蔚
基本信息 | ||
姓名: | 程蔚蔚 | |
职称: | 主任医师 | |
导师类型: | 博士生导师 | |
专业: | 妇产科学 | |
研究方向: | 妊娠高血压的病理妊娠 先天性心脏病的早期诊断及发生机制 | |
邮箱地址: | wwcheng29@163.com | |
个人简介 | ||
程蔚蔚,主任医师、博士生导师。国务院津贴获得者,上海市产前诊断技术质控中心主任,担任上海市优生优育科学协会副会长,中国优生科学协会副会长,上海市母婴安全专家委员会副主任委员及上海市医师协会母胎医学医师分会会长等多项社会职务。上海市第十一届、十二届、十三届政协委员,上海市第十三、十四届妇女联合会执委。 从事妇产科学30余年,聚焦国际产科前沿科学研究,主要研究方向为母胎疾病、高危妊娠以及罕见病产前诊断。主持参与了包括国自然、上海市科委以及上海市卫健委的30余项项目,发表60余篇SCI论文以及多篇中文核心论文,主编参编多项产科相关专家指南和共识。曾获上海医学科技奖三等奖、全国妇幼健康科学技术奖三等奖、华夏医学科技奖三等奖、医树奖二等奖、上海市先进工作者、上海市五一劳动奖章、上海市三八红旗手以及上海市劳模创新工作室等称号。
主持项目: 1. 上海交通大学中国医院发展研究院,专科运营推动妇产类医院高质量发展的路径和策略研究 2. 上海交通大学,21405GFY,上海交通大学医学院临床教学培训示范中心 3. 上海市卫生健康委员会,202140091,lnc-c17orf64-1:1调控自噬参与子痫前期发生以及早期临床预测作用研究 4. 上海申康医院发展中心,SHDC2020CR6021,子痫前期-子痫的队列数据库建设,分中心主持 5. 徐汇区科委,2021-006,基于5G+的人工智能远程母胎监护应用体系建设 6. 上海市科学技术委员会,20DZ2305000,“千种出生缺陷,一个声音”出生缺陷综合防控科普宣传 7. 上海交通大学“转化医学交叉基金”重点项目,ZH2018ZDA31,环状RNA在子痫前期的分子机制和早期诊断预测中的研究 8. 上海市科委创新项目,18411963500,胎儿先天性心脏病早中孕期一体化筛查及诊断体系建立 9. 徐汇区卫计委重要疾病联合攻关项目,XHLHGG201805,高龄及二胎围产期保健体系优化研究 10. 上海市申康医院发展中心,SHDC2016608,基于医疗失效模式和效应分析的(HFMEA)的产科急重症安全管理模式的构建 11. 上海市卫计委计划生育类项目,201640361,子痫前期胎盘自噬对子代心血管内皮损伤及高血压疾病的干预研究 12. 上海申康医院发展中心,16CR4019A,联合胎儿心超及基因诊断对先天性心脏病进行产前筛查及诊断的技术推广 13. 国家自然科学基金面上项目,81370727,母-胎界面免疫微环境恶化导致子痫发生的信息转导机制 14. 上海交通大学医学院临床潜力学科,KJ20104100102,围产医学 15. 上海市市级医院新兴前沿技术联合攻关项目,SHDC12013114,唐氏综合征产前筛查质量控制体系建设 16. 上海市科委医学引导类科技项目,134119a1101,脂质代谢及内皮脂酶表达对子痫前期预测及诊断价值的研究 17. 上海交通大学“医工(理)交叉研究基金”面上项目,YG2012MS27,唐氏综合征预防干预的公共卫生服务网络和质量保证体系建设 18. 上海市申康医院发展中心临床管理优化项目,SHDC12012627,区域孕产妇电子健康档案的建设 19. 上海交通大学医学院自然科学研究基金项目,12XJ10037,利用Array-CGH 技术进行胎儿心脏发育异常的发病机制研究 20. 上海市卫生局局级课题面上项目,20114137,饱和氢水干预先兆子痫鼠动物模型的研究 21. 上海市人口计生委项目,2010JG05,降低出生缺陷建立一体化的孕前检查指导模式 22. 上海市科委“创新行动计划”基础研究重点项目,10JC1419300,抑癌基因R-1 在恶性妇科肿瘤早期诊断中的临床基础研究 23. 上海市科委重大专项子课题,10DZ1951205,妊娠早中期心脏发育异常胎儿染色体核型分析及临床应用价值的研究
近5年代表性论文(通讯作者): 1. Shen, H., Chen, D., Wang, S., Jin, Y., & Cheng, W. (2024). Effects of dietary fiber on maternal health in pregnant women with metabolic syndrome risk: a randomized controlled trial. Food & Function. 2. Xiong, Y., Zheng, P., Chen, C., He, C., Yang, X., & Cheng, W. (2024). Association of maternal serum uric acid levels with LBW/SGA: a large retrospective cohort study. BMC Pregnancy and Childbirth, 24(1), 160. 3. Xiong, Y., Chen, C., He, C., Yang, X., & Cheng, W. (2024). Identification of shared gene signatures and biological mechanisms between preeclampsia and polycystic ovary syndrome. Heliyon, 10(8). 4. Chen, C., Lei, Z., Xiong, Y., Ni, M., He, B., Gao, J., ... & Cheng, W. (2023). Gestational weight gain of multiparas and risk of primary preeclampsia: a retrospective cohort study in Shanghai. Clinical Hypertension, 29(1), 32. 5. Li, M., Ye, B., Chen, Y., Gao, L., Wu, Y., & Cheng, W. (2023). Analysis of genetic testing in fetuses with congenital heart disease of single atria and/or single ventricle in a Chinese prenatal cohort. BMC pediatrics, 23(1), 577. 6. Cai, Q., Shi, S., Shen, H., Ye, B., & Cheng, W. (2023). Combined general and central obesity indices to predict gestational diabetes. The Journal of Maternal-Fetal & Neonatal Medicine, 36(1), 2183765. 7. Lang, X., Liu, W., Chen, Q., Yang, X., Chen, D., & Cheng, W. (2023). Resveratrol inhibits multiple organ injury in preeclampsia rat model. Acta Biochimica Polonica, 70(1), 131-135. 8. Biwei, H., Min, S., Yanlin, W., Xinrong, Z., Li, G., Renyi, H., ... & Weiwei, C. (2022). Case report: Prenatal diagnosis of Ectrodactyly–Ectodermal dysplasia–Cleft syndrome (EEC) in a fetus with cleft lip and polycystic kidney. Frontiers in Genetics, 13, 1002089. 9. Xie, X., Chen, D., Yang, X., Cao, Y., Guo, Y., & Cheng, W. (2023). Combination of Maternal Serum ESM-1 and PLGF with Uterine Artery Doppler PI for Predicting Preeclampsia. Journal of Clinical Medicine, 12(2), 459. 10. Gao, J., Xiao, Z., Chen, C., Shi, H. W., Yang, S., Chen, L., ... & Cheng, W. (2023). Development and Validation of a Small for Gestational Age Screening Model at 21–24 Weeks Based on the Real-World Clinical Data. Journal of Clinical Medicine, 12(8), 2993. 11. Chen, C., Gao, J., Chen, D., Liu, J., He, B., Chen, Y., ... & Cheng, W. (2022). miR-4443/MMP2 suppresses the migration and invasion of trophoblasts through the HB-EGF/EGFR pathway in preeclampsia. Cell Cycle, 21(23), 2517-2532. 12. Jinyu, L., Shuying, W., Panchan, Z., Dan, C., Chao, C., Xingyu, Y., & Weiwei, C. (2022). Bone marrow stromal cell antigen 2 (BST2) suppresses the migration and invasion of trophoblasts in preeclampsia by downregulating matrix metallopeptidase 2 (MMP2). Bioengineered, 13(5), 13174-13187. 13. Lang, X., Chen, Z., Yang, X., Yan, Q., Xu, M., Liu, W., ... & Zhao, W. (2021). Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/FOXO1 signaling. Journal of Biochemical and Molecular Toxicology, 35(10), e22870. 14. Jing, G., Huwei, S., Chen, L., Ping, W., Zhongzhou, X., Sen, Y., ... & Weiwei, C. (2022). A Predictive Model of Macrosomic Birth Based on Real-World Clinical Data in Pregnant Women.BMC pregnancy and child 15. Zheng, P., Chen, D., Ye, B., Yang, X., & Cheng, W. (2022). Association between placental implantation abnormalities and hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology Research, 48(3), 654-662. 16. Chen, D., He, B., Zheng, P., Wang, S., Zhao, X., Liu, J., ... & Cheng, W. (2021). Identification of mRNA-, circRNA-and lncRNA-associated ceRNA networks and potential biomarkers for preeclampsia from umbilical vein endothelial cells. Frontiers in molecular biosciences, 8, 652250. 17. Wei, X., Chen, Y., & Cheng, W. (2021). Efficacy of Precesarean Infrarenal Abdominal Aorta Balloon Occlusion Among Women With Pernicious Placenta Previa and Placenta Accreta: A Retrospective Cohort Analysis. 18. Lang, X., Liu, W., Hou, Y., Zhao, W., Yang, X., Chen, L., ... & Cheng, W. (2021). IL-17A polymorphism (rs2275913) and levels are associated with preeclampsia pathogenesis in Chinese patients. BMC Medical Genomics, 14(1), 1-8.2区,3.622 19. Ye, B., Wu, Y., Chen, J., Yang, Y., Niu, J., Wang, H., ... & Cheng, W. (2021). The diagnostic value of the early extended fetal heart examination at 13 to 14 weeks gestational age in a high-risk population. Translational Pediatrics, 10(11), 2907. 20. Yuan, J., Mao, Z., Lu, Q., Xu, P., Wang, C., Xu, X., ... & Cheng, W. (2021). Hypermethylated PCDHGB7 as a Biomarker for Early Detection of Endometrial Cancer in Endometrial Brush Samples and Cervical Scrapings. Frontiers in Molecular Biosciences, 8. 21. Li, Y., Zhao, X., He, B., Wu, W., Zhang, H., Yang, X., & Cheng, W. (2021). Autophagy Activation by Hypoxia Regulates Angiogenesis and Apoptosis in Oxidized Low-Density Lipoprotein-Induced Preeclampsia. Frontiers in molecular biosciences, 8. 22. Shen, H., Zhao, X., Li, J., Chen, Y., Liu, Y., Wang, Y., ... & Cheng, W. (2020). Severe early-onset PE with or without FGR in Chinese women. Placenta, 101, 108-114. 23. Xueya, Z., Yamei, L., Sha, C., Dan, C., Hong, S., Xingyu, Y., & Weiwei, C. (2020). Exosomal encapsulation of miR-125a-5p inhibited trophoblast cell migration and proliferation by regulating the expression of VEGFA in preeclampsia. Biochemical and Biophysical Research Communications, 525(3), 646-653. 24. Lang, X., Zhao, W., Huang, D., Liu, W., Shen, H., Xu, L., ... & Cheng, W. (2019). The role of NUDT21 in microRNA‐binding sites of EZH2 gene increases the risk of preeclampsia. Journal of Cellular and Molecular Medicine, 23(5), 3202-3213. 25. Liu, Y., Zhu, W., Le, S., Wu, W., Huang, Q., & Cheng, W. (2020). Using healthcare failure mode and effect analysis as a method of vaginal birth after caesarean section management. Journal of Clinical Nursing, 29(1-2), 130-138. 26. Wu, Y., Wang, Y., Wen, S. W., Zhao, X., Hu, W., Liu, C., ... & Cheng, W. (2018). Recombinant chromosome 4 in two fetuses-case report and literature review. Molecular Cytogenetics, 11, 1-8. 27. He, B., Yang, X., Li, Y., Huang, D., Xu, X., Yang, W., ... & Cheng, W. (2018). TLR9 (toll-like receptor 9) agonist suppresses angiogenesis by differentially regulating VEGFA (vascular endothelial growth factor a) and sFLT1 (soluble vascular endothelial growth factor receptor 1) in preeclampsia. Hypertension, 71(4), 671-680. 28. Hu, X., Ao, J., Li, X., Zhang, H., Wu, J., & Cheng, W. (2018). Competing endogenous RNA expression profiling in pre-eclampsia identifies hsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia. Clinical Epigenetics, 10, 1-12.
代表性著作: 1. 程蔚蔚、王丽萍、华人意主编,小豆丁的365天,围孕期生活指南,中国福利会出版社,2023年 2. 程蔚蔚主译,《分娩与助产实践(第4版)》,2020年,世界图书出版公司 3. 程蔚蔚主编,《上海市围生保健技术发展报告》,上海交通大学出版社,2020年 4. 程蔚蔚、王丽萍主编,《准妈妈体重管理全攻略》,世界图书出版上海有限公司,2019年 5. 王玉东、程蔚蔚主编,《妇产科应用解剖与手术技巧(第二版》,上海交通大学出版社,2018年 6. 程蔚蔚主编,《孕产专家细说怀孕》,江苏科学技术出版社,2015年 7. 程蔚蔚主编,《怀孕胎教280天》,江苏科学技术出版社,2015年 8. 王玉东、程蔚蔚主编,《妇产科应用解剖与手术技巧》,上海科学技术文献出版社,2014年 9. 范建霞、程蔚蔚主译,《妊娠》,上海科学技术出版社,2014年 10. 程蔚、花琪主编,《痛经与经前期综合征》中国医药科技出版社,2009年 11. 程蔚蔚、黄勇主编,《妇科炎症》,中国医药科技出版社, 2009年 12. 程蔚蔚、王丽华主编,《子宫肌瘤》,中国医药科技出版社,2009年 13. 程蔚蔚、骆月娥主编,《妊娠期病症》,中国医药科技出版社,2009年 14. 程蔚蔚、陈焱主编,《产后病》,中国医药科技出版社, 2009年 15. 程蔚蔚主编,《产科精要》,江苏科学技术出版社,2009年 程蔚蔚主编,《妊娠.分娩.育儿一本通》,江苏科学技术出版社,2008年
|